Panel: Why Are We Not Doing Better? An Open Discussion of the Limitations of Current Drug Development for GBM and Where the Field Can Improve
Time: 9:25 am
- Barriers to advancing drug development and strategies to address these
- Major therapeutic strategies currently under development
- How can drug developers cut to the real barriers, and debate what is truly required to break through to successful treatments for GBM?